US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 3.180
  • +0.160+5.30%
Close Nov 1 16:00 ET
112.12MMarket Cap-5344P/E (TTM)

FibroBiologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
54.04%3.22M
52.32%3.45M
98.99%8.89M
90.18%2.48M
52.95%2.05M
2.09M
2.27M
183.08%4.47M
1.3M
1.34M
Selling and administrative expenses
45.47%2.25M
39.34%2.49M
96.42%6.52M
78.00%1.71M
48.74%1.48M
--1.55M
--1.79M
214.10%3.32M
--959K
--993K
-General and administrative expense
45.47%2.25M
39.34%2.49M
96.42%6.52M
78.00%1.71M
48.74%1.48M
--1.55M
--1.79M
214.10%3.32M
--959K
--993K
Research and development costs
78.24%975K
100.84%960K
106.45%2.37M
124.06%773K
64.94%574K
--547K
--478K
120.15%1.15M
--345K
--348K
Operating profit
-54.04%-3.22M
-52.32%-3.45M
-98.99%-8.89M
-90.18%-2.48M
-52.95%-2.05M
-2.09M
-2.27M
-183.08%-4.47M
-1.3M
-1.34M
Net non-operating interest income expense
750.00%65K
125.93%35K
77.52%-147K
99.55%-1K
0
-10K
-135K
-16,250.00%-654K
-220K
-221K
Non-operating interest income
--70K
--39K
----
----
----
--0
--0
----
----
----
Non-operating interest expense
-50.00%5K
-97.04%4K
-77.52%147K
-99.55%1K
--0
--10K
--135K
16,250.00%654K
--220K
--221K
Other net income (expense)
7,217.54%4.06M
-33,533.33%-5.05M
-7.45M
-7.24M
-141K
-57K
-15K
Gain on sale of security
--4.03M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
152.63%30K
-33,533.33%-5.05M
---7.45M
---7.24M
---141K
---57K
---15K
----
----
----
Income before tax
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
-2.16M
-2.42M
-223.70%-5.12M
-1.52M
-1.56M
Income tax
Net income
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
-2.16M
-2.42M
-223.70%-5.12M
-1.52M
-1.56M
Net income continuous Operations
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
-223.70%-5.12M
---1.52M
---1.56M
Minority interest income
Net income attributable to the parent company
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
-2.16M
-2.42M
-223.70%-5.12M
-1.52M
-1.56M
Preferred stock dividends
Other preferred stock dividends
0
0
2.57M
0
0
0
2.57M
0
0
0
Net income attributable to common stockholders
141.57%898K
-69.61%-8.46M
-272.15%-19.06M
-537.60%-9.72M
-40.33%-2.19M
-2.16M
-4.99M
-223.70%-5.12M
-1.52M
-1.56M
Basic earnings per share
145.11%0.03
-75.80%-0.27
-272.15%-0.5868
-537.60%-0.2992
-40.33%-0.0675
-0.0665
-0.1536
-223.71%-0.1577
-0.0469
-0.0481
Diluted earnings per share
145.11%0.03
-75.80%-0.27
-272.15%-0.5868
-537.60%-0.2992
-40.33%-0.0675
-0.0665
-0.1536
-223.71%-0.1577
-0.0469
-0.0481
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 54.04%3.22M52.32%3.45M98.99%8.89M90.18%2.48M52.95%2.05M2.09M2.27M183.08%4.47M1.3M1.34M
Selling and administrative expenses 45.47%2.25M39.34%2.49M96.42%6.52M78.00%1.71M48.74%1.48M--1.55M--1.79M214.10%3.32M--959K--993K
-General and administrative expense 45.47%2.25M39.34%2.49M96.42%6.52M78.00%1.71M48.74%1.48M--1.55M--1.79M214.10%3.32M--959K--993K
Research and development costs 78.24%975K100.84%960K106.45%2.37M124.06%773K64.94%574K--547K--478K120.15%1.15M--345K--348K
Operating profit -54.04%-3.22M-52.32%-3.45M-98.99%-8.89M-90.18%-2.48M-52.95%-2.05M-2.09M-2.27M-183.08%-4.47M-1.3M-1.34M
Net non-operating interest income expense 750.00%65K125.93%35K77.52%-147K99.55%-1K0-10K-135K-16,250.00%-654K-220K-221K
Non-operating interest income --70K--39K--------------0--0------------
Non-operating interest expense -50.00%5K-97.04%4K-77.52%147K-99.55%1K--0--10K--135K16,250.00%654K--220K--221K
Other net income (expense) 7,217.54%4.06M-33,533.33%-5.05M-7.45M-7.24M-141K-57K-15K
Gain on sale of security --4.03M------------------------------------
Other non- operating income (expenses) 152.63%30K-33,533.33%-5.05M---7.45M---7.24M---141K---57K---15K------------
Income before tax 141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M-2.16M-2.42M-223.70%-5.12M-1.52M-1.56M
Income tax
Net income 141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M-2.16M-2.42M-223.70%-5.12M-1.52M-1.56M
Net income continuous Operations 141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M---2.16M---2.42M-223.70%-5.12M---1.52M---1.56M
Minority interest income
Net income attributable to the parent company 141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M-2.16M-2.42M-223.70%-5.12M-1.52M-1.56M
Preferred stock dividends
Other preferred stock dividends 002.57M0002.57M000
Net income attributable to common stockholders 141.57%898K-69.61%-8.46M-272.15%-19.06M-537.60%-9.72M-40.33%-2.19M-2.16M-4.99M-223.70%-5.12M-1.52M-1.56M
Basic earnings per share 145.11%0.03-75.80%-0.27-272.15%-0.5868-537.60%-0.2992-40.33%-0.0675-0.0665-0.1536-223.71%-0.1577-0.0469-0.0481
Diluted earnings per share 145.11%0.03-75.80%-0.27-272.15%-0.5868-537.60%-0.2992-40.33%-0.0675-0.0665-0.1536-223.71%-0.1577-0.0469-0.0481
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data